Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
Launched by DUKE UNIVERSITY · Jul 22, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Baby Steps III clinical trial is studying a new way to help pregnant women quit smoking. Researchers want to see if sending text messages with tips to stop smoking, along with special training for doctors who care for pregnant women, can help more women successfully quit smoking during their pregnancy. The trial will recruit women who report smoking when they visit their doctor for the first time during pregnancy. Both groups of women will receive support through text messages, but only the doctors in the study group will get extra training on how to help their patients quit smoking.
To participate, women need to be at least 18 years old, receiving prenatal care from a participating doctor, and must be able to send and receive text messages. They also need to be able to speak and read English. This study is considered to have minimal risk, meaning it’s safe for participants. If you join, you can expect to receive supportive messages throughout your pregnancy to help you quit smoking, and the research team will look at the results to see how effective the program is.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years old
- • Receiving prenatal care from an enrolled OB clinician
- • Self-report smoking tobacco at their first OB visit
- • Access to a cell phone with texting capabilities
- Exclusion Criteria:
- • Unable to speak and read English
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Kathryn I Pollak, PhD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials